期刊文献+

氨甲酰化促红细胞生成素逆转慢性心力衰竭大鼠左室重构的研究 被引量:2

Carbamylated erythropoietin reverses left ventricular remodeling in rats with chronic heart failure
下载PDF
导出
摘要 目的:探讨氨甲酰化促红细胞生成素(CEPO)对慢性心力衰竭(CHF)大鼠左心室重构的影响。方法:健康雄性Wistar大鼠90只,随机选取10只作为对照组,其余腹腔注射异丙肾上腺素(ISO)进行造模。5周后将造模成功者再分为CHF组和CEPO组,后者腹腔注射CEPO50μg/kg,2次/周,CHF组和对照组同期腹腔注射等量生理盐水,4周后检测各组大鼠血流动力学指标、血浆B型脑钠肽(BNP)水平,并计算左心室重量指数(LVW/BW)。结果:与对照组相比,CHF组左室内压峰值(LVSP)、左室内压上升/下降最大速率(±dp/dtmax)显著降低,左室舒张末压(LVEDP)显著升高(P<0.05),血浆BNP水平显著升高(P<0.05),LVW/BW也显著升高(P<0.05)。与CHF组相比,CEPO组LVSP、±dp/dtmax均显著升高,而LVEDP则显著降低(P<0.05),血浆BNP水平显著降低(P<0.01),LVW/BW也显著降低(P<0.05)。结论:CEPO可通过降低血浆BNP水平、减轻左心室重构来改善CHF大鼠的心功能。 Objective To explore the effect of carbamylated erythropoietin on left ventricular remodeling in rats with chronic heart failure (CHF). Methods 10 of 90 healthy male wistar rats were randomly assigned to control group,the rest received intraperitoneal injections of isoproterenol to establish a model of CHF. After 5 weeks,the survived rats were randomly divided into CHF group and CEPO group.CEPO group was administered intraperitoneal injections of CEPO of 50μg/kg twice a week for 4 weeks;CHF group and the control group received equivalent saline. After the completion of CEPO injection, hemodynamic, level of BNP, and the ratio of left ventricular weight to body weight (LVW/BW) were measured. Results As compared with the control group, left ventricular end systolic pressure (LVSP), maximal rate of rise/decline of left ventricular pressure (:t:dp/dtmax) were significantly decreased in CHF group(P 〈 0.05), whereas left ventricular end diastolic pressure (LVEDP), level of BNP and the ratio of left ventrieular weight to body weight (LVW/BW) were significantly higher (P 〈 0.05). As compared with CHF group, LVSP and ±dp/dtmax were significantly increased (P 〈 0.05), while LVEDP, level of BNP, and LVW/BW were significantly decreased (P 〈 0.05) in CEPO group. Conclusions CEPO can improve cardiac function in rats with CHF by reducing BNP level and alleviating cardiac remodeling.
出处 《实用医学杂志》 CAS 北大核心 2011年第8期1350-1352,共3页 The Journal of Practical Medicine
基金 甘肃省新药临床前研究重点实验室开放基金项目(编号:GSKFKT-0707)
关键词 慢性心力衰竭 氨甲酰化促红细胞生成素 B型脑钠肽 心室重构 Heart failure Carbamylatederythropoietin Brainnatriureticpeptide Ventricularremodeling
  • 相关文献

参考文献9

  • 1Moon C, Krawczyk M, Paik D, et al. Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties [J]. J Pharmacol Exp Ther, 2006,316 (3) :999-1005.
  • 2Tonnessen T, Christensen G, Oie E, et al. Increased cardiac expression of endothelin-1 mRNA in ischemic heart failure in rats [J]. Cardiovasc Res, 1997,33(3):601-610.
  • 3Lipsic E, Westenbrink B D, van der Meer P, et al. Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit [J]. Eur J Heart Fail, 2008,10( 1 ) : 22-29.
  • 4林瑾仪,邹云增,孙爱军,梁艳艳,葛均波.促红细胞生成素促心肌细胞肥大的实验研究[J].中国分子心脏病学杂志,2009,9(5):272-276. 被引量:1
  • 5邱红,朱红枫.氯沙坦对心力衰竭大鼠心肌细胞凋亡和Ca^(2+)变化的影响[J].实用医学杂志,2009,25(14):2241-2243. 被引量:5
  • 6Xu X, Cao Z, Cao B, et al. Carhamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism [J]. Surgery,2009, 146(3) :506-514.
  • 7王静,宋耀鸿,李宝石,蔡辉.淫羊藿总黄酮对异丙肾上腺素致心力衰竭大鼠心肌基质金属蛋白酶-2和基质金属蛋白酶-9的影响[J].实用医学杂志,2010,26(6):949-951. 被引量:8
  • 8Fiordaliso F, Chimenti S, Staszewsky L, et al. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury [J]. Proc Natl Acad Sci U S A, 2005,102(6):2046-2051.
  • 9Xu K, George I, Klotz S, et al. Erythropoietin Derivate Improves Left Ventricular Systolic Performance and Attenuates Left Ventricular Remodeling in Rats with Myocardial Infarct- Induced Heart Failure [J]. J Cardiovasc Pharmacol, 2010,56 (5) :506-512.

二级参考文献14

  • 1张秀娥,成蓓,何平,余其振.钙调磷酸酶在β肾上腺素能刺激诱导心肌凋亡中的作用[J].实用医学杂志,2005,21(1):10-12. 被引量:2
  • 2许兰芝,陈维宁.淫羊藿总黄酮对肾上腺素能受体阻断作用的研究[J].中国药理学通报,1994,10(4):311-313. 被引量:64
  • 3杨永曜,李隆贵.心肌细胞凋亡与心室重构的关系[J].心脏杂志,2006,18(1):95-96. 被引量:10
  • 4Khoynezhad A.Promising aspects and caveats of studies on antiapoptotic therapies in patients with heart failure[J].Eur J Heart Fail,2007,9(2):120-123.
  • 5Abdelwahid E,mith G.Apoptosis in chronic heart failure[J].Int J Cardiol,2007,18,(3):375-378.
  • 6Miner E C,Miller W L.A Look Between the Cardiomyocytes:The Extracellular Matrix in Heart Failure[J].Mayo Clin Proc,2006,81 (1):71-76.
  • 7Fondard O,Detaint D and lung B,et al.Extraeellnlar matrix remodelling in human aortic valve disease:the role of matrix metalloproteinases and their tissue inhibitors[J].Eur Heart J,2005,26(13):1333-1341.
  • 8Teerlink J R,Pfeffer J M,Pfeffer M A.Progressive ventricular remodeling in response to diffuse isoproterenol-indueed myocardial necrosis in rats[J].Circ Res,1994,75 (1):105-113.
  • 9Davani S,Marandin A and Mersin N,et al.Mesenchymal progenitor cells differentiate into an endothelial phenotype,enhaned vascular density,and improve heart function in a rat cellular cardiomyoplasty model[J].Circulation,2003,108(11):253-258.
  • 10Dorn GW 2nd.Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodeling[J].Cardiovasc Res,2009,81 (3):465-473.

共引文献11

同被引文献22

  • 1王命基,刘志勇,陆献成,张运生.PPAR-γ激动剂环格列酮对大鼠心肌缺血再灌注损伤保护作用的研究[J].现代医学,2007,35(5):344-349. 被引量:5
  • 2李宓,邹和群.促红细胞生成素对慢性肾衰竭患者免疫功能的影响[J].中国血液净化,2005,4(4):193-196. 被引量:18
  • 3Lorenzo S,Halliwill JR,Sawka MN,Minson CT. Heat acclimation improves exercise performance[J].Journal of Applied Physiology,2010,(04):1140-1147.
  • 4Lorenzo S,MINSON C T. Heat acclimation improves cutaneous vascular function and sweating in trained cyclists[J].Journal of Applied Physiology,2010,(06):1736-1743.
  • 5Harrison MH. Effects on thermal stress and exercise on blood volume in humans[J].Physiological Reviews,1985,(01):149-209.
  • 6Hubbard RW,Matthew WT,Horstman D,Francesconi R Mager M Sawka MN. Albumin-induced plasma volume expansion:diurnal and temperature effects[J].Journal of Applied Physiology,1984,(05):1361-1368.
  • 7Harrison MH,Edwards RJ,Fennessy PA. Intravascular volume and tonicity as factors in the regulation of body temperature[J].Journal of Applied Physiology,1978,(01):69-75.
  • 8Iwai M,Stetler RA,Xing J. Enhanced Oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury[J].Stroke,2010.1032-1037.
  • 9Lacombe C. Biology oferythmpoietin[J].Hematological,1998,(08):724-732.
  • 10Maxwell PH,Ferguson DJP,Nicholls LG,Iredale JP Pugh CW Johnson MH Ratcliffe PJ. Sites oferythropoietin production[J].Kidney International,1997,(02):393-401.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部